$Jiutian Chemical (C8R.SG)$ Jiutian Chemical Group has issue...
Jiutian Chemical Group has issued a profit warning for FY2023 ended Dec 31, 2023, saying it expects to announce a net loss for the full-year period.
In a Feb 15 bourse filing, its Board of Directors says this is mainly due to a decline in the average selling prices of its main products - dimethylformamide and methylamine - arising from an industry-wide softening of demand and significant production capacity added by a new competitor since 4Q2022.
The competitor is Jiangxi Xinlianxin Chemical Industry, a subsidiary of Henan XinLianXin Chemical Group Co. Ltd.
Jiutian has not announced when it will release its FY2023 results, but its Board says it will do so no later than Feb 29. The company announced its previous set of full-year results, for FY2022, on Feb 28, 2023.
Jiutian announced on Jan 13 its plans to spend RMB1.6 billion ($296.96 million) in a bid to broaden its product offerings and gain better control over its supply chain.
Jiutian, based in China's Henan Province, currently produces dimethylformamide and methylamine, sodium hydrosulfate and dimethylacetamide (DMAC).
Jiutian plans to expand into producing and selling synthetic ammonia by tapping on the right to undertake such a project in Henan now held by Anyang Chemical Industry Group, deemed as its controlling shareholder.
In its business update for 3QFY2023 ended Sep 30, 2023, Jiutian reported a net loss of RMB68.6 million, from earnings of RM93.5 million recorded a year prior. Sales in the same period plunged by 85% y-o-y to RMB80.2 million.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Moo Contributor
Follow me to get useful analysis, learn TA and make profitable trades.
Maximise profit 利润最大化
6630Followers
57Following
23KVisitors
Follow
MiltonWong : 0.020 here we come
♤方展博♤ : Expected loss for FY2023. How much losses is the crucial part.
MiltonWong ♤方展博♤: should be very bad, dmf prices and methylamine only one way down the entire year...in fact im shocked they want to propose this new business model which will increase their capex and put them back into huge debt. they barely got into net cash only 2 years ago off a lucky break when their competitors closed shop...they should follow china sunsine or hualu hengsheng to do share buyback to support share price in last 6 months; ironically this mgmt decided to go back to square 1 which is the 0.01-0.02 path lol
bullrider_21OP MiltonWong: Will the profit from the new business offset their loss?
MiltonWong bullrider_21OP: not sure, china price slump for all manufactured pdts